Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


18.04.2017

1 Am J Clin Pathol
1 Am J Gastroenterol
2 Ann Surg
1 BMC Cancer
1 Cancer Lett
9 Eur J Surg Oncol
1 Gastroenterology
1 Int J Oncol
2 Lancet Gastroenterol Hepatol
1 Oncol Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. FASSAN M, Saraggi D, Balsamo L, Realdon S, et al
    Early miR-223 Upregulation in Gastroesophageal Carcinogenesis.
    Am J Clin Pathol. 2017;147:301-308.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. HATTA W, Gotoda T, Oyama T, Kawata N, et al
    A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: "eCura system".
    Am J Gastroenterol. 2017 Apr 11. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    Ann Surg

  3. CHEN XZ, Chen HN, Liu K, Zhang WH, et al
    Perineural Invasion Underlines the Necessity of Upper Lesser Curvature Skeletonization in Radical Distal Gastrectomy for Locally Advanced Gastric Cancer.
    Ann Surg. 2017;265:e67-e68.
    PubMed     Text format    

  4. CEYHAN GO
    Reply to Letter: "Neural Invasion Cannot be Controlled by Extended Surgery in Gastric Cancer".
    Ann Surg. 2017;265:e68-e69.
    PubMed     Text format    


    BMC Cancer

  5. XING X, Cai W, Ma S, Wang Y, et al
    Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer.
    BMC Cancer. 2017;17:268.
    PubMed     Text format     Abstract available


    Cancer Lett

  6. GEN Y, Yasui K, Kitaichi T, Iwai N, et al
    ASPP2 suppresses invasion and TGF-beta1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
    Cancer Lett. 2017 Apr 8. pii: S0304-3835(17)30232.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  7. KULIG P, Sierzega M, Pach R, Kolodziejczyk P, et al
    Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.
    Eur J Surg Oncol. 2016;42:1215-21.
    PubMed     Text format     Abstract available

  8. O'NEILL AC, Shinagare AB, Kurra V, Tirumani SH, et al
    Assessment of metastatic risk of gastric GIST based on treatment-naive CT features.
    Eur J Surg Oncol. 2016;42:1222-8.
    PubMed     Text format     Abstract available

  9. MESSAGER M, de Steur W, Boelens PG, Jensen LS, et al
    Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).
    Eur J Surg Oncol. 2016;42:1432-47.
    PubMed     Text format     Abstract available

  10. KIM S, Paget-Bailly S, Messager M, Nguyen T, et al
    Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma.
    Eur J Surg Oncol. 2017;43:218-225.
    PubMed     Text format     Abstract available

  11. CAPELLI L, Petracci E, Quagliuolo V, Saragoni L, et al
    Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.
    Eur J Surg Oncol. 2016;42:1206-14.
    PubMed     Text format     Abstract available

  12. PARRY K, van Rossum PS, Haj Mohammad N, Ruurda JP, et al
    The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis.
    Eur J Surg Oncol. 2017;43:226-233.
    PubMed     Text format     Abstract available

  13. PARK JM, Kim HI, Han SU, Yang HK, et al
    Who may benefit from robotic gastrectomy?: A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy.
    Eur J Surg Oncol. 2016;42:1944-1949.
    PubMed     Text format     Abstract available

  14. LEHMANN K, Eshmuminov D, Bauerfeind P, Gubler C, et al
    18FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma.
    Eur J Surg Oncol. 2017;43:196-202.
    PubMed     Text format     Abstract available

  15. BOURAS G, Markar SR, Burns EM, Huddy JR, et al
    The psychological impact of symptoms related to esophagogastric cancer resection presenting in primary care: A national linked database study.
    Eur J Surg Oncol. 2017;43:454-460.
    PubMed     Text format     Abstract available


    Gastroenterology

  16. ISHIMOTO T, Miyake K, Nandi T, Yashiro M, et al
    Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
    Gastroenterology. 2017 Apr 5. pii: S0016-5085(17)35398.
    PubMed     Text format     Abstract available


    Int J Oncol

  17. FUJIWARA Y, Okada K, Omori T, Sugimura K, et al
    Multiple therapeutic peptide vaccines for patients with advanced gastric cancer.
    Int J Oncol. 2017;50:1655-1662.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  18. SHITARA K, Takashima A, Fujitani K, Koeda K, et al
    Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.
    Lancet Gastroenterol Hepatol. 2017;2:277-287.
    PubMed     Text format     Abstract available

  19. LORDICK F
    Salvage chemotherapy for advanced gastric cancer: more than a false hope?
    Lancet Gastroenterol Hepatol. 2017;2:240-241.
    PubMed     Text format    


    Oncol Rep

  20. LI X, Li J, Li F
    P21 activated kinase 4 binds translation elongation factor eEF1A1 to promote gastric cancer cell migration and invasion.
    Oncol Rep. 2017;37:2857-2864.
    PubMed     Text format     Abstract available


    PLoS One

  21. DAI M, Yuan F, Fu C, Shen G, et al
    Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0175357.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: